Myofibroblasts Derived from Hepatic Progenitor Cells Create the Tumor Microenvironment

Area of Science:

• Hepatology and stem cell biology
• Liver disease pathogenesis
• Cancer microenvironment research

Background:

• Chronic liver injury can lead to fibrosis, cirrhosis, and cancer.
• Hepatic progenitor cells (HPCs) are implicated in liver disease but their role is debated.
• HPCs are typically defined by their potential to become hepatocytes and cholangiocytes.

Purpose of the Study:

• To investigate the differentiation potential of Hepatic Progenitor Cells (HPCs) beyond hepatocytes and cholangiocytes.
• To determine if HPCs contribute to the tumor microenvironment in chronic liver injury.
• To re-evaluate the definition and role of HPCs in liver disease pathogenesis.

Main Methods:

• Isolation of HPCs from chronically injured rodent livers.
• In vitro cell culture to assess differentiation potential.
• Analysis of HPC contribution to tumor microenvironment during tumor development.

Main Results:

• HPCs isolated from injured livers can differentiate into myofibroblasts, a third cell type.
• Myofibroblast differentiation from HPCs is minimal in standard culture conditions.
• HPCs significantly contribute to myofibroblast production within the tumor microenvironment during tumor development.

Conclusions:

• Hepatic progenitor cells (HPCs) possess a previously unrecognized potential to differentiate into myofibroblasts.
• This myofibroblast differentiation is specifically activated during liver tumor formation.
• HPCs play a critical role in shaping the tumor microenvironment, potentially supporting tumor growth and survival.